Results

Total Results: 727 records

Showing results for "free".

21. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
    January 01, 2009 - Completion Date: 3-24-10 1 Results of Topic Selection Process & Next Steps  Serum free … Summary: The nominator presents a series of questions for a review on the effectiveness of serum free … are interested in multiple myeloma (MM), including nonsecretory multiple myeloma (NSMM), and either free … Population(s): Any patient diagnosed with one of the B-plasma cell dyscrasias (i.e., MM, free light … Serum Free Light Chain Assay Analysis Nomination Summary Document http://effectivehealthcare.ahrq.gov

22. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
    January 01, 2023 - breast irradiation (WBI) in terms of ipsilateral breast recurrence (IBR), overall survival, and cancer-free … 10, and over 10 years (high SOE), with no difference in overall survival (low to high SOE), cancer-free … survival (high SOE), or mastectomy-free survival (low to high SOE). … IORT showed no difference in overall survival, cancer-free survival, or mastectomy-free survival (low … interstitial brachytherapy compared with WBI showed no difference in IBR, overall survival, cancer-free

23. Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
    October 31, 2023 - No significant difference was found in CR, progression-free or event-free survival between arms. … Insufficient IMRT vs. 3D CRT Locoregional recurrence- free, distant metastasis-free, and colostomy-free … Insufficient Overall, disease-specific, disease-free, and relapse- free survival 1; NRSI; n=424 … high-dose boost (20-25 Gy; total dose, 65-70 Gy) Overall, disease-free, colostomy-free, and disease … none Overall, progression-free, colostomy-free, and disease- specific survival 1; RCT; n=940 No

24. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
    August 01, 2012 - 1 Comparative Effectiveness Review Number 73 Serum Free Light Chain Analysis for the Diagnosis, Management … expanded clone of malignant plasma cells produces an excess of either intact immunoglobulin or free … Serum free light chains for monitoring multiple myeloma. … Serum free light chain measurements move to center stage. … Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.

25. The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
    August 27, 2012 - Calculation Renal Cell Carcinoma Image: Bar chart showing 3 month, 5-month, and 10-month progression-free … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Calculation Renal Cell Carcinoma Image: Bar chart showing 3 month, 5-month, and 10-month progression-free … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal

26. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay/research
    August 23, 2012 - Research Protocol Aug. 23, 2012 Systematic Review Jun. 28, 2013 Disposition of Comments Report Serum Free … Structured Abstract Objectives To summarize the literature regarding the role of the serum free light

27. Cer-242-Radiation-Therapy-Brain-Metastases-Evidence-Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
    June 01, 2021 - We did not detect effects of hippocampal sparing WBRT on overall survival, disease-free survival, or … A Technical Expert Panel advised on key outcomes: overall survival, disease-free survival, deaths due … and we did not detect effects of memantine or hippocampal sparing WBRT on overall survival, disease-free … postoperative WBRT specifically (overall survival HR 0.93; CI 0.68 to 1.27; 4 RCTs; low SoE; disease-free … There was insufficient evidence for important outcomes including disease-free survival, intracranial

28. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - Lasmiditan 100 mg Pain free at 2 hours Poor/None RR: 1.78; 95% CI: 1.58 to 2.00; I² =N/A Pain free … Placebo Pain free at 2 hours Poor/None RR: 4.93; 95% CI: 4.12 to 5.91; I² =N/A Pain free at 2 hours … Lasmiditan 100 mg Disability free 2 hours RR: 1.32; 95% CI: 0.83 to 2.08; I² =N/A Disability free … Placebo Disability free 2 hours RR: 1.90; 95% CI: 1.14 to 3.18; I² =N/A Disability free 24 hours … Placebo Disability free 2 hours RR: 1.44; 95% CI: 0.83 to 2.52; I² =N/A Disability free 24 hours

29. New SRDR Functionality: Import FHIR-formatted Citation Files for Systematic Reviews | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/news/fhir-formatted-citation-files
    FHIR-formatted Citation Files for Systematic Reviews SRDR+ , an AHRQ-funded tool, is a free

30. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - scale, restored function, and function scale at 2 hours; pain free, sustained pain free and pain … and pain relief at 2 hours, and sustained pain free at 24 hours and 48 hours. … There was no significant difference in pain relief and pain free at 2 hours. … pain free at 2 days. … There was no significant difference in pain relief and pain free at 2 hours.

31. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - scale, restored function, and function scale at 2 hours; pain free, sustained pain free, and pain … and pain relief at 2 hours, and sustained pain free at 24 hours and 48 hours. … There was no significant difference in pain relief and pain free at 2 hours. … pain free at 2 days. … There was no significant difference in pain relief and pain free at 2 hours.

32. Acute Treatment for Episodic Migraine: Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - Lasmiditan 100 mg Pain free at 2 hours Poor/None RR: 1.78; 95% CI: 1.58 to 2.00; I² =N/A Pain free … Placebo Pain free at 2 hours Poor/None RR: 4.93; 95% CI: 4.12 to 5.91; I² =N/A Pain free at 2 hours … Lasmiditan 100 mg Disability free 2 hours RR: 1.32; 95% CI: 0.83 to 2.08; I² =N/A Disability free … Placebo Disability free 2 hours RR: 1.90; 95% CI: 1.14 to 3.18; I² =N/A Disability free 24 hours … Placebo Disability free 2 hours RR: 1.44; 95% CI: 0.83 to 2.52; I² =N/A Disability free 24 hours

33. Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/epilepsy-medicine/research
    December 21, 2011 - Results Patients given newer antiepileptic medications were less likely to be seizure free for 6–12 … There was no significant difference in the risk of being seizure free for the study duration when newer … antiepileptic medications were compared against phenytoin or valproic acid, or the risk of being seizure free

34. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
    June 01, 2022 - , restored function, and function scale at 2 hours; pain free, sustained pain free, and pain relief … sustained pain free at 1 day and at 2 days. … There was also no difference in terms of sustained pain free at 2 days. … at 2 hours and 1 day, and sustained pain free at 1 day and 2 days. … pain free at 2 days.

35. Online Training for SRDR Now Available at the Evidence Synthesis Academy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/news/srdr-plus-online-training
    EPC) program launched SRDR+ , an updated version of the Systematic Review Data Repository (SRDR), a free

36. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
    July 18, 2017 - evidence low] ) ( [evidence insufficient] ) Similar ( [evidence low] ) Local Recurrence-Free … evidence medium] ) Favors RN ( [evidence low] ) ( [evidence insufficient] ) Metastasis-Free … RR of mortality 0.33 (0.25 to 0.44) [evidence low] Metastasis-free survival 8 (2,462) Similar … results RR of metastasis 1.53 (0.27 to 8.63) [evidence medium] Local recurrence-free survival … survival 2 (217) Similar results NA [evidence low] Local recurrence-free survival 2 (217

37. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - ��) Overall Survival at 5 Years Favors PN (���)b Similar (���) (���) Similar (���) Local Recurrence-Free … Survival Favors PN (���) Similar (���) Favors RN (���) (���) Metastasis-Free Survival Similar (���) … 1.53 (0.27 to 8.63) ��� Local recurrence-free survival 14 (3,916) Better with PN. … 13 (2,513) Similar results RR of metastasis 0.35 (0.08 to 1.46) ��� Local recurrence-free survival … 2 (217) Similar results NA ��� Local recurrence-free survival 2 (217) Better results with RN, but

38. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - scale, restored function, and function scale at 2 hours; pain free, sustained pain free and pain … and pain relief at 2 hours, and sustained pain free at 24 hours and 48 hours. … There was no significant difference in pain relief and pain free at 2 hours. … pain free at 2 days. … There was no significant difference in pain relief and pain free at 2 hours.

39. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - scale, restored function, and function scale at 2 hours; pain free, sustained pain free and pain … and pain relief at 2 hours, and sustained pain free at 24 hours and 48 hours. … There was no significant difference in pain relief and pain free at 2 hours. … pain free at 2 days. … There was no significant difference in pain relief and pain free at 2 hours.

40. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0443_06-01-2011.pdf
    January 01, 2011 - imaging modalities alone or in combination for improvements in tumor staging, prediction of tumor-free … modalities alone or in combination Outcome(s): Appropriate tumor staging, accurate prediction of tumor-free